Spots Global Cancer Trial Database for geltamo
Every month we try and update this database with for geltamo cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma | NCT01014208 | Lymphoma, Large... | OFATUMUMAB + DH... RITUXIMAB + DHA... | 18 Years - | GlaxoSmithKline | |
Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom | NCT00646750 | Non-Hodgkin's L... | Ybritumomab Tiu... | 18 Years - 70 Years | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | |
Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL) | NCT00644371 | Non-Hodgkin Lym... | Ibritumomab Tiu... | 18 Years - 65 Years | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | |
Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom | NCT00646750 | Non-Hodgkin's L... | Ybritumomab Tiu... | 18 Years - 70 Years | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea |